Compare ZWS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZWS | BIO |
|---|---|---|
| Founded | 1891 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.7B |
| IPO Year | 2012 | N/A |
| Metric | ZWS | BIO |
|---|---|---|
| Price | $47.60 | $305.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $47.50 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 828.9K | 189.5K |
| Earning Date | 02-03-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.94% | N/A |
| EPS Growth | ★ 42.52 | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | $1,659,400,000.00 | ★ $2,557,500,000.00 |
| Revenue This Year | $9.03 | $1.62 |
| Revenue Next Year | $5.39 | $2.26 |
| P/E Ratio | $42.97 | ★ N/A |
| Revenue Growth | ★ 6.88 | N/A |
| 52 Week Low | $27.74 | $211.43 |
| 52 Week High | $50.03 | $373.69 |
| Indicator | ZWS | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 57.85 | 40.79 |
| Support Level | $45.69 | $306.52 |
| Resistance Level | $47.53 | $316.63 |
| Average True Range (ATR) | 1.04 | 9.57 |
| MACD | 0.09 | -1.13 |
| Stochastic Oscillator | 91.61 | 14.79 |
Zurn Elkay Water Solutions Corp designs procures, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The company's product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.